Eurofins Opens First Commercial Post-Entry Plant Quarantine Facility in Australia
September 11 2014 - 1:00AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Agisearch, part of the Eurofins Agroscience Services
group, the largest agrochemical and veterinary medicines Contract
Research Organisation in the world, announces the opening of their
new state-of-the-art quarantine facility located in Toowoomba,
Queensland. The facility will replace the previous government
quarantine facility at Eagle Farm, Brisbane, for seed imports into
Australia. The facility was officially opened on Wednesday 10
September by John Chapman, Managing Director, Agri-Science
Queensland, Department of Agriculture Fisheries and Forestry
Queensland.
Following the announcement of the closure of the Eagle Farm
post-entry quarantine facility, the Department of Agriculture
Fisheries and Forestry has worked closely with Eurofins Agrisearch
and the federal Department of Agriculture to facilitate the
establishment of a new commercial post-entry quarantine service.
Eurofins Agrisearch is Australia’s largest independent Contract
Research Organisation and has close ties with the seed industry
providing both field and laboratory based research.
This new investment by Eurofins Agrisearch provides an even
greater commitment to support agricultural development in
Australia. Such a development would not be feasible, either
economically or logistically without industry and government
participation. The result of over a year of planning is that a
large proportion of post-entry quarantine for future seed imports
has been outsourced to Eurofins Agrisearch who has designed,
constructed and staffed this new regionally based facility. The
facility is equipped with the latest environmental monitoring and
control features and has a low environmental footprint, being
largely powered by solar energy and having its own, on-site, waste
treatment plant. With 300m² of bench space it has the capacity for
up to 10,000 plants at a time. The facility will mainly cater for
corn, cotton, sorghum, sunflower and pulses but will be available
for both summer and winter cereal crops and will provide a secure
quarantine service for the Australian seed industry well into the
future.
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food and
pharmaceutical products testing. It is also number one in the world
in the field of environmental laboratory services and one of the
global market leaders in agroscience, genomics, discovery
pharmacology and central laboratory services.
With over 16,000 staff in more than 200 laboratories across 36
countries, Eurofins offers a portfolio of over 100,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products. The Group provides its customers with
high-quality services, accurate results on time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the NYSE
Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA,
Bloomberg ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
For more information please visit www.eurofins.com
or contact:Investor RelationsEurofins ScientificPhone: + 32
2 766 1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024